SARS-CoV-2, the causative agent of COVID-19, has profound systemic effects, including significant impacts on the central nervous system (CNS). Emerging evidence suggests a potential link between SARS-CoV-2-induced neuroinflammation and the exacerbation or initiation of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). This review explores the mechanisms by which SARS-CoV-2 may contribute to neurodegenerative processes. We first discuss the pathways of viral entry into the CNS, including transneuronal and hematogenous routes, leading to blood-brain barrier (BBB) dysfunction. Neuroinflammation, mediated by the activation of microglia and astrocytes and the release of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β, is highlighted as a critical factor exacerbating neuronal damage. Oxidative stress and vascular damage are further examined as complementary mechanisms promoting neurodegeneration. In addition, we review how SARS-CoV-2 infection influences proteinopathies by accelerating the aggregation of pathological proteins like alpha-synuclein, tau, and TDP-43, contributing to disease progression in PD, AD, and related disorders. Clinical studies reporting cognitive and motor dysfunctions in post-COVID-19 patients with pre-existing neurodegenerative diseases are also summarized. Finally, this review identifies knowledge gaps and emphasizes the need for further research to clarify the long-term neurological consequences of SARS-CoV-2 infection. Understanding these mechanisms is critical for developing targeted therapeutic strategies to mitigate the risk of neurodegeneration in vulnerable populations.
Neurodegenerative diseases (NDs) such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) are growing public health concerns worldwide, and their burden is particularly severe in low- and middle-income countries, including Nigeria. This perspective highlights the urgent need for tailored public health strategies to address the rising prevalence of these diseases, focusing on prevention, early detection, and management in the Nigerian context. With an aging population and limited healthcare infrastructure, Nigeria faces unique challenges in diagnosing and treating NDs. Cultural factors, such as stigma and misconceptions about cognitive decline, further complicate timely intervention. The paper explores the current public health strategies implemented to combat these diseases, including lifestyle modifications, national policy development, and public-private partnerships. It emphasizes the need for community-based programs, the integration of primary healthcare and neurology, and increased awareness to reduce the societal burden of NDs. Additionally, the manuscript discusses the essential role of training healthcare providers and the integration of traditional and modern medicine in enhancing care. It calls for a coordinated, culturally relevant approach to addressing the rising tide of neurodegenerative diseases in Nigeria, with recommendations for policy reform, healthcare system strengthening, and greater research investment.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has evolved in different waves and is currently in its third wave for the majority of countries around the world. Each wave emanated with its own set of challenges. Lower- and middle-income countries such as most African countries have faced additional challenges compared to high-income countries. This paper highlights the challenges faced by Africa during the third wave of COVID-19 and proposes recommendations and strategies to contain the spread. We conducted a mini-review for the newly released articles and researches about the challenges faced by Africa during COVID-19. Fragmented healthcare sectors, limited healthcare resources and emergence of co-infections in COVID-19 patients, inadequate vaccination rollout and political conflicts are the major challenges faced by the African countries. Our recommendations to defeat this outbreak and subsequent pandemics is to raise the public's awareness about vaccines through campaigns and social media in order to lessen vaccine hesitancy. Governments as well should focus on under-served and vulnerable populations, patients with comorbidities, and communities living in endemic-striking settings as these people are more prone to the severe form of the disease. Moreover, by adopting socio-ecological perspectives, one can implement multi-level integrated interventions to help control COVID-19 more effectively.
Background: Many professions undergo continuous training to keep abreast of happenings and current trends. Pharmacy is one of such profession; it achieves this by participating in Mandatory continuing professional development (MCPD). MCPDs come in various forms, including seminars, conference attendance, and reading research journals. Aim: This study sets out to assess and explore pharmacists’ attitudes towards continuing education in Nigeria and investigate the perceived barriers that hinder pharmacists from being involved in continuing education (CE) activities. Methods: A validated questionnaire composed of 19 items was shared online among pharmacists practicing in different settings in Nigeria. Descriptive and inferential statistics were used to analyse the variables. Results: A total of 586 pharmacists participated in the study. A high percentage (77.8%) of those who completed the questionnaire strongly agreed that life-long learning is a professional responsibility of all pharmacists to increase their knowledge. A fair number of the participants (52.90%) adopted a positive attitude toward CE, while almost a similar percentage (47.10%) of participants displayed poor attitudes. The main barriers identified were the lack of time (49.10%), the cost of (MCPD) programmes (65.90%), and job constraints (64.80%). Conclusion: This study showed that the attitude of Nigerian Pharmacists toward CE is polarised between positive and negative, with several factors impeding their involvement in CE.
The emergence of antimicrobial resistance has necessitated the search for novel therapeutic agents from natural sources. This study evaluated the phytochemical composition of Ficus globosa latex and assessed its antimicrobial activity against selected pathogenic microorganisms. Latex was collected, authenticated, and processed through acetone precipitation followed by drying at 60°C for three weeks. Both fresh and dried latex samples underwent phytochemical screening using standard methods, revealing abundant quantities of resins, steroids, and terpenoids; moderate levels of flavonoids; and trace amounts of fats, oils, and hydrolysable glycosides. Antimicrobial activity was evaluated using the agar well diffusion method against eight pathogenic microorganisms. The dried latex demonstrated significant antimicrobial activity with minimum inhibitory concentrations (MICs) of 3.89 mg/mL against Bacillus subtilis, 14.79 mg/mL against Staphylococcus aureus, and 8.13 mg/mL against Aspergillus niger. In contrast, fresh latex showed activity only against B. subtilis. F. globosa latex exhibits promising antimicrobial activity, particularly against gram-positive bacteria, warranting further investigation for therapeutic applications. The presence of multiple bioactive compounds suggests potential mechanisms for its antimicrobial effects.
5 April 2025 in Afro-Egyptian Journal of Infectious and Endemic Diseases
Background and study aim: The review article explores effective community engagement strategies for Mpox prevention and response. Key approaches include targeted education campaigns, behavioral change communication, community-based surveillance, and engagement of underserved populations. Community participation in outbreak containment and collaboration with health authorities is emphasized. Case studies from Nigeria and Sudan demonstrate successful community-official partnerships in Mpox outbreak responses. The effectiveness of engagement strategies is evaluated, and policy implications are discussed, recommending integration of community involvement into national Mpox prevention frameworks. Crucial policy considerations include prioritizing high-risk groups, establishing clear guidelines, allocating sufficient resources, and ensuring inclusivity. Conclusion: For effective global Mpox control, a multifaceted approach involving community engagement, targeted interventions, improved surveillance, and vaccination programs is needed. By implementing comprehensive strategies that leverage community participation and address the zoonotic nature of the disease through a One Health approach, significant progress can be made in Mpox prevention and control efforts worldwide. This review underscores the critical role of community engagement in creating sustainable and effective public health interventions for Mpox.